These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 32972546)

  • 41. Association of Tafamidis With Health Status in Patients With ATTR Cardiac Amyloidosis: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial.
    Sperry BW; Hanna M; Maurer MS; Nativi-Nicolau J; Floden L; Stewart M; Wyrwich KW; Barsdorf AI; Kapadia H; Spertus JA
    JAMA Cardiol; 2023 Mar; 8(3):275-280. PubMed ID: 36723935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?
    Aus dem Siepen F; Hein S; Prestel S; Baumgärtner C; Schönland S; Hegenbart U; Röcken C; Katus HA; Kristen AV
    Clin Res Cardiol; 2019 Dec; 108(12):1324-1330. PubMed ID: 30953182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prevalence of sinus rhythm in patients with "permanent" atrial fibrillation.
    Ziegler PD; Sakaguchi S; Simons GR; Koehler JL; Warman E
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):674-81. PubMed ID: 24499313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study.
    García-Pavía P; Manuel García-Pinilla J; Lozano-Bahamonde A; Yun S; García-Quintana A; Gavira-Gómez JJ; Aibar-Arregui MÁ; Barge-Caballero G; Villota JN; Bernal L; Tarilonte P
    Rev Esp Cardiol (Engl Ed); 2024 Jul; ():. PubMed ID: 39089574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of recurrence rates after direct-current cardioversion for new-onset atrial fibrillation in patients receiving versus those not receiving rhythm-control drug therapy.
    Li H; Riedel R; Oldemeyer JB; Rovang K; Hee T
    Am J Cardiol; 2004 Jan; 93(1):45-8. PubMed ID: 14697464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Left atrial pressure pattern without a-wave in sinus rhythm after cardioversion affects the outcomes after catheter ablation for atrial fibrillation.
    Kishima H; Mine T; Takahashi S; Ashida K; Ishihara M; Masuyama T
    Heart Vessels; 2018 Nov; 33(11):1365-1372. PubMed ID: 29691642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage.
    Law S; Petrie A; Chacko L; Cohen OC; Ravichandran S; Gilbertson JA; Rowczenio D; Wechalekar A; Martinez-Naharro A; Lachmann HJ; Whelan CJ; Hutt DF; Hawkins PN; Fontana M; Gillmore JD
    ESC Heart Fail; 2020 Dec; 7(6):3942-3949. PubMed ID: 32924285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Atrial fibrillation: always cardioversion? No].
    Di Pasquale G; Biancoli S; Sassone B; Pancaldi LG
    Ital Heart J Suppl; 2002 Jan; 3(1):81-90. PubMed ID: 11899578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications.
    Balciunaite G; Rimkus A; Zurauskas E; Zaremba T; Palionis D; Valeviciene N; Aidietis A; Serpytis P; Rucinskas K; Sogaard P; Glaveckaite S; Zorinas A; Janusauskas V
    Hellenic J Cardiol; 2020; 61(2):92-98. PubMed ID: 31740363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time to cardioversion of recurrent atrial arrhythmias after catheter ablation of atrial fibrillation and long-term clinical outcome.
    Baman TS; Gupta SK; Billakanty SR; Ilg KJ; Good E; Crawford T; Jongnarangsin K; Ebinger M; Pelosi F; Bogun F; Chugh A; Morady F; Oral H
    J Cardiovasc Electrophysiol; 2009 Dec; 20(12):1321-5. PubMed ID: 19602031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrophysiological Manifestations of Cardiac Amyloidosis:
    Hartnett J; Jaber W; Maurer M; Sperry B; Hanna M; Collier P; Patel DR; Wazni OM; Donnellan E
    JACC CardioOncol; 2021 Oct; 3(4):506-515. PubMed ID: 34729522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electrical Dyssynchrony in Cardiac Amyloidosis: Prevalence, Predictors, Clinical Correlates, and Outcomes.
    Martens P; Hanna M; Valent J; Mullens W; Ives L; Kwon DH; Rickard J; Tang WHW
    J Card Fail; 2022 Dec; 28(12):1664-1672. PubMed ID: 35882259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation].
    Potpara T; Marinković-Erić J; Grujić M; Radojković-Cirović B; Vujisić-Tesić B; Petrović M
    Srp Arh Celok Lek; 2002; 130(5-6):189-92. PubMed ID: 12395441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis.
    Aimo A; Fabiani I; Giannoni A; Mandoli GE; Pastore MC; Vergaro G; Spini V; Chubuchny V; Pasanisi EM; Petersen C; Poggianti E; Taddei C; Castiglione V; Latrofa S; Panichella G; Sciaccaluga C; Georgiopoulos G; Passino C; Cameli M; Emdin M
    Eur Heart J Cardiovasc Imaging; 2022 Dec; 24(1):130-141. PubMed ID: 35292807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of transthyretin cardiac amyloidosis in elderly patients diagnosed with heart failure.
    Jaramillo-Hidalgo J; Quezada-Feijoó M; Ramos M; Toro R; Gómez-Pavón J; Ayala-Muñoz R
    Rev Esp Geriatr Gerontol; 2023; 58(1):8-14. PubMed ID: 36404188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Self-reported sleep quality of patients with atrial fibrillation and the effects of cardioversion on sleep quality.
    Kayrak M; Gul EE; Aribas A; Akilli H; Alibasiç H; Abdulhalikov T; Yildirim O; Yazici M; Ozdemir K
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):823-9. PubMed ID: 23437796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of Right Atrial Impairment and Association with Outcomes in Cardiac Amyloidosis.
    Singulane CC; Slivnick JA; Addetia K; Asch FM; Sarswat N; Soulat-Dufour L; Mor-Avi V; Lang RM
    J Am Soc Echocardiogr; 2022 Aug; 35(8):829-835.e1. PubMed ID: 35398489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of Orthopedic Manifestations in Patients With Cardiac Amyloidosis With a Focus on Shoulder Pathologies.
    Basdavanos A; Maurer MS; Ives L; Derwin K; Ricchetti ET; Seitz W; Hanna M
    Am J Cardiol; 2023 Mar; 190():67-74. PubMed ID: 36566619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac amyloidosis: a significant blind spot of the H2FPEF score.
    Duca F; Rettl R; Binder C; Dusik F; Schrutka L; Dalos D; Öztürk B; Capelle CD; Qin H; Dachs TM; Camuz Ligios L; Agis H; Kain R; Hengstenberg C; Badr-Eslam R; Kastner J; Bonderman D
    Panminerva Med; 2023 Dec; 65(4):491-498. PubMed ID: 36789997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
    Paton DM
    Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.